Beta blockers for acute traumatic brain injury: A systematic review and meta-analysis

Neurocritical Care

Volumn 20, Issue 3, 2014, Pages 514-523

  Alali, Aziz S ^a,b,c   McCredie, Victoria A ^b,d   Golan, Eyal ^b,e   Shah, Prakesh S ^b,f   Nathens, Avery B ^a,b,g,h  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

Author keywords

Beta blocker; Catecholamine; Head injury; Traumatic brain injury

Indexed keywords

ATENOLOL; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CARVEDILOL; CLONIDINE; ESMOLOL; INOTROPIC AGENT; LABETALOL; METOPROLOL; NADOLOL; PLACEBO; PROPRANOLOL; SOTALOL;

ACUTE BRAIN DISEASE; ADULT; BRADYCARDIA; BRONCHOSPASM; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL (TOPIC); DESCRIPTIVE RESEARCH; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HIGH RISK PATIENT; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; QUANTITATIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; RISK REDUCTION; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; ACUTE DISEASE; BRAIN INJURIES;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; BRAIN INJURIES; HUMANS;

EID: 84902379382     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9903-5     Document Type: Review

References (39)

1. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728-41. (Pubitemid 351957931)
2. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehab. 2006;21:375-8. (Pubitemid 44413110)
3. Shackford SR, Mackersie RC, Holbrook TL, Davis JW, Hollingsworth-Fridlund P, Hoyt DB, Wolf PL. The epidemiology of traumatic death. A population-based analysis. Arch Surg. 1993;128:571-5. (Pubitemid 23143223)
4. Thurman D, Guerrero J. Trends in hospitalization associated with traumatic brain injury. JAMA. 1999;282:954-7. (Pubitemid 29420314)
5. Park E, Bell JD, Baker AJ. Traumatic brain injury: can the consequences be stopped? CMAJ. 2008;178:1163-70. (Pubitemid 351596226)
6. Neil-Dwyer G, Cruickshank JM, Doshi R. The stress response in subarachnoid haemorrhage and head injury. Acta Neurochir Suppl. 1990;47:102-10.
7. Hortnagl H, Hammerle AF, Hackl JM, Brucke T, Rumpl E, Hortnagl H. The activity of the sympathetic nervous system following severe head injury. Intensive Care Med. 1980;6:167-9.
8. McLeod AA, Neil-Dwyer G, Meyer CH, Richardson PL, Cruickshank J, Bartlett J. Cardiac sequelae of acute head injury. Br Heart J. 1982;47:221-6. (Pubitemid 12179917)
9. Ley EJ, Scehnet J, Park R, Schroff S, Dagliyan G, Conti PS, Margulies DR, Salim A. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma. 2009;66:154-9; discussion 159-161.
10. Ley EJ, Park R, Dagliyan G, Palestrant D, Miller CM, Conti PS, Margulies DR, Salim A. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma. 2010;68:353-6.
11. Ley EJ, Clond MA, Bukur M, Park R, Chervonski M, Dagliyan G, Margulies DR, Lyden PD, Conti PS, Salim A. Beta-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury. J Trauma Acute Care Surg. 2012;73(1):33-40.
12. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001;345:1223-9. (Pubitemid 34951485)
13. Arbabi S, Ahrns KS, Wahl WL, Hemmila MR, Wang SC, Brandt MM, Taheri PA. Beta-blocker use is associated with improved outcomes in adult burn patients. J Trauma. 2004;56:265-9; discussion 269-271.
14. Asgeirsson B, Grande PO, Nordstrom CH. A new therapy of posttrauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Med. 1994;20:260-7. (Pubitemid 24132365)
15. Naredi S, Eden E, Zall S, Stephensen H, Rydenhag B. A standardized neurosurgical neurointensive therapy directed toward vasogenic edema after severe traumatic brain injury: clinical results. Intensive Care Med. 1998;24:446-51. (Pubitemid 28274156)
16. Grande PO, Nordstrom CH, Asgeirsson B. Current alternative therapy of post-traumatic brain edema. Nord Med. 1994;109:157-9.
17. Tran TY, Dunne IE, German JW. Beta blockers exposure and traumatic brain injury: a literature review. Neurosurg Focus. 2008;25:E8.
18. Heffernan DS, Inaba K, Arbabi S, Cotton BA. Sympathetic hyperactivity after traumatic brain injury and the role of beta-blocker therapy. J Trauma. 2010;69:1602-9.
19. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
20. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/ nosgen.pdf.
21. Steyerberg EW, Mushkudiani N, Perel P, et al. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008;5(8):e165; discussion e165.
22. Schroeppel TJ, Fischer PE, Zarzaur BL, Magnotti LJ, Clement LP, Fabian TC, Croce MA. Beta-adrenergic blockade and traumatic brain injury: protective? J Trauma. 2010;69:776-80.
23. Salim A, Hadjizacharia P, Brown C, Inaba K, Teixeira PGR, Chan L, Rhee P, Demetriades D. Significance of troponin elevation after severe traumatic brain injury. J Trauma. 2008;64:46-52.
24. Riordan WP Jr, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris JA Jr. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007;63:503-10; discussion 510-501.
25. Inaba K, Teixeira PGR, David J-S, Chan LS, Salim A, Brown C, Browder T, Beale E, Rhee P, Demetriades D. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008;206:432-8. (Pubitemid 351282525)
26. Hadjizacharia P, O'Keeffe T, Brown CVR, Inaba K, Salim A, Chan LS, Demetriades D, Rhee P. Incidence, risk factors, and outcomes for atrial arrhythmias in trauma patients. Am Surg. 2011;77:634-9.
27. Cruickshank JM, Neil-Dwyer G, Degaute JP, Hayes Y, Kuurne T, Kytta J, Vincent JL, Carruthers ME, Patel S. Reduction of stress/catecholamine-induced cardiac necrosis by beta 1-selective blockade. Lancet. 1987;2:585-9. (Pubitemid 17123396)
28. Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, Morris JA Jr. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62:26-33; discussion 33-25.
29. Bukur M, Mohseni S, Ley E, Salim A, Margulies D, Talving P, Demetriades D, Inaba K. Efficacy of beta-blockade after isolated blunt head injury: does race matter? [Erratum appears in J Trauma Acute Care Surg. 2012 Jun;72(6):1725 Note: Mosheni, Shahin [corrected to Mohseni, Shahin]]. J Trauma Acute Care Surg. 2012;72:1013-18.
30. Arbabi S, Campion EM, Hemmila MR, Barker M, Dimo M, Ahrns KS, Niederbichler AD, Ipaktchi K, Wahl WL. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007;62:56-61; discussion 61-52.
31. Chiolero RL, Breitenstein E, Thorin D, Christin L, de Tribolet N, Freeman J, Jequier E, Schutz Y. Effects of propranolol on resting metabolic rate after severe head injury. Crit Care Med. 1989;17:328-34. (Pubitemid 19108363)
32. Zlotnik A, Klin Y, Gruenbaum BF, Gruenbaum SE, Ohayon S, Leibowitz A, Kotz R, Dubilet M, Boyko M, Shapira Y, Teichberg VI. Beta2 Adrenergic-mediated reduction of blood glutamate levels and improved neurological outcome after traumatic brain injury in rats. J Neurosurg Anesthesiol. 2012;24:30-8.
33. Larson B, Beal A, Ahari A, Russell S, Freeman K. Beta-adrenergic blockade prevents myocardial oxidative stress due to traumatic brain injury. Ann Emerg Med. 2009;1:S142-3.
34. Liu MY. Protective effects of propranolol on experimentally head-injured mouse brains. J Formos Med Assoc. 1995;94:386-90.
35. Larson BE, Stockwell DW, Boas S, Andrews T, Wellman GC, Lockette W, Freeman K. Cardiac reactive oxygen species after traumatic brain injury. J Surg Res. 2012;173:e73-81.
36. Leitman IM. Understanding the brain-heart axis in neurological trauma. J Surg Res. 2012;173:e33-5.
37. Hortnagl H, Hammerle AF, Hackl JM, Brucke T, Rumpl E. The activity of the sympathetic nervous system following severe head injury. Intensive Care Med. 1980;6:167-9.
38. Naredi S, Olivecrona M, Lindgren C, Ostlund AL, Grande PO, Koskinen LOD. An outcome study of severe traumatic head injury using the "Lund therapy" with low-dose prostacyclin. Acta Anaesthesiol Scand. 2001;45:402-6. (Pubitemid 32234730)
39. Eker C, Asgeirsson B, Grande PO, Schalen W, Nordstrom CH. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Crit Care Med. 1998;26:1881-6. (Pubitemid 28527702)